CBIZ (CBZ) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved year-over-year growth in revenue, profitability, net income, and free cash flow for Q1 2026, with organic growth improving sequentially and integration milestones advancing.
AI and automation initiatives advanced, with measurable productivity gains and deployment across 200 workflows, supporting scalable future growth.
Strategic priorities include talent acquisition, brand investment, industry verticals, and AI-driven efficiency, positioning as a middle-market leader.
Share repurchases totaled ~$63M YTD through April, reducing net leverage by ~0.5x year-over-year.
Integration efforts resulted in unified teams, systems, and culture, with improved organic growth and cost synergy estimates exceeding $50M by 2027.
Financial highlights
Q1 2026 consolidated revenue rose 1.3% year-over-year to $849M; organic revenue growth was 1%.
Adjusted EBITDA increased 1.5% to $244M, with margin up 10bps to 28.8%.
Adjusted diluted EPS grew 7.3% to $2.50; net income rose 31.6% to $162M.
Free cash flow improved by $64M year-over-year, aided by a $57.2M–$58M one-time acquisition-related gain.
Net leverage decreased to 3.4x from 3.9x year-over-year.
Outlook and guidance
2026 revenue guidance reaffirmed at $2.8B–$2.9B, representing 2%–5% year-over-year growth.
Adjusted EBITDA guidance raised to $465M–$475M; adjusted diluted EPS outlook increased to $4.00–$4.10.
Free cash flow expected at $270M–$290M, with ~60% conversion at the midpoint.
Long-term goals include 8–10% revenue growth and 1.5x–2x earnings growth.
Expect organic growth to accelerate in the second half as integration impacts abate.
Latest events from CBIZ
- Revenue up 52% with strong margin gains; 2026 outlook targets 2–5% growth and higher cash flow.CBZ
Q4 202514 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at annual meeting.CBZ
Proxy filing2 Apr 2026 - Director elections, auditor ratification, and executive pay are key agenda items, with robust governance and ESG focus.CBZ
Proxy filing2 Apr 2026 - Q2 revenue up 5.4%; $2.3B Marcum deal to close Q4, creating a top-7 U.S. accounting provider.CBZ
Q2 20242 Feb 2026 - Balanced organic and acquisition-driven growth, high retention, and margin expansion drive outperformance.CBZ
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 adjusted EPS up 27.3% and Marcum acquisition completed, boosting scale and leverage.CBZ
Q3 202418 Jan 2026 - Acquisition of Marcum creates a top-7 firm, boosting scale, recurring revenue, and growth prospects.CBZ
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Q1 2025 revenue up 69.5% to $838M, adjusted EBITDA doubled, Marcum integration on track.CBZ
Q1 202525 Dec 2025 - 2025 guidance: $2.90–$2.95B revenue, $3.60–$3.65 adjusted EPS, $450M–$456M EBITDA.CBZ
Q4 202421 Dec 2025